Relative Costs and Outcomes of a Contrast-Enhanced Mammography-Guided Biopsy Trial
CEM Bx demonstrates high success rates and satisfaction scores. CEM Bx resulted in shorter procedure times, enhanced operational efficiency, and ~45% reduction in costs compared with MRI Bx. As advancements continue, we anticipate CEM Bx will offer a cost-efficient and timely option for breast biopsy.
Authors
- Marie A. Ganott
- Amy E. Kelly (ORCID: https://orcid.org/0000-0002-9971-8033)
- Bhavika Patel (ORCID: https://orcid.org/0000-0002-8486-955X)
- Jameson Cumsky (ORCID: https://orcid.org/0000-0003-2065-6456)
- Richard E. Sharpe (ORCID: https://orcid.org/0000-0001-8309-4863)
- Margarita L. Zuley
- Bronwyn Nair (ORCID: https://orcid.org/0009-0000-3385-7439)
- Laura K Harper (ORCID: https://orcid.org/0000-0002-6127-1547)
- Molly B. Carnahan (ORCID: https://orcid.org/0000-0001-9323-150X)
- Uzma Waheed (ORCID: https://orcid.org/0000-0001-8208-9456)
- Victor J. Pizzitola
- Abeer Mousa
- Kimberly Harnist
- Adrienne Vargo (ORCID: https://orcid.org/0009-0009-3632-1512)
Institutions
- Mayo Clinic Hospital (US)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Journal of Breast Imaging
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1093/jbi/wbaf019
- Citations
- 1
- Primary Topic
- Digital Radiography and Breast Imaging
- Type
- article
- Field-Weighted Citation Impact
- 1.52